Department of Chemistry, Kookmin University, 861-1 Jeongneung-dong, Seongbuk-gu, Seoul 136-702, Republic of Korea.
Bioorg Med Chem Lett. 2012 Dec 15;22(24):7335-9. doi: 10.1016/j.bmcl.2012.10.085. Epub 2012 Oct 23.
Human microsomal prostaglandin E synthase-1 (mPGES-1) is an emerging drug target for inflammatory disorders and cancer suppression. Therefore, it is crucially important to discover mPGES-1 inhibitors with novel structural scaffolds for the development of anti-inflammatory drugs. Here, we report the mPGES-1 inhibitors identified through screening of a chemical library. Initial screening of 1841 compounds out of 200,000 in a master library resulted in 9 primary hits. From the master library, 387 compounds that share the scaffold structure with the 9 primary hit compounds were selected, of which 3 compounds showed strong inhibitory activity against mPGES-1 having IC(50) values of 1-3 μM. Notably, a derivative of sulfonylhydrazide, compound 3b, inhibited the LPS-induced PGE(2) production in RAW 264.7 cells. This compound showed novel scaffold structure compared to the known inhibitors of mPGES-1, suggesting that it could be further developed as a potent mPGES-1 inhibitor.
人微粒体前列腺素 E 合酶-1(mPGES-1)是炎症性疾病和癌症抑制的新兴药物靶点。因此,发现具有新型结构骨架的 mPGES-1 抑制剂对于抗炎药物的开发至关重要。在这里,我们报告了通过化学文库筛选鉴定的 mPGES-1 抑制剂。从主库中筛选出 200,000 个化合物中的 1841 个化合物,得到了 9 个初步命中。从主库中选择了 387 种与 9 个初步命中化合物具有相同结构骨架的化合物,其中 3 种化合物对 mPGES-1 具有较强的抑制活性,IC(50)值为 1-3 μM。值得注意的是,磺酰基腙衍生物 3b 抑制了 LPS 诱导的 RAW 264.7 细胞中 PGE(2)的产生。与已知的 mPGES-1 抑制剂相比,该化合物具有新型骨架结构,表明它可以进一步开发为有效的 mPGES-1 抑制剂。